Flavored products, disposable devices, and a wide variety of brands threaten the health of our nation’s youth
Embargoed Until: Thursday, October 6, 2022, 1:00 p.m. ET
Contact: Media Relations
A study released today from the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention (CDC) found that 2.55 million U.S. middle and high school students reported current (past 30-day) e-cigarette use in 2022, which includes 14.1% of high school students and 3.3% of middle school students. Nearly 85% of those youth used flavored e-cigarettes and more than half used disposable e-cigarettes.
Among youth who currently used e-cigarettes, 14.5% reported their usual brand was Puff Bar, followed by Vuse (12.5%), Hyde (5.5%), and SMOK (4.0%); more than one fifth (21.8%) reported their usual brand was a brand other than the 13 listed in the survey.
The findings, published in the Morbidity and Mortality Weekly Report, are based on data from the 2022 National Youth Tobacco Survey (NYTS), a cross-sectional, self-administered survey of U.S. middle (grades 6–8) and high (grades 9–12) school students, which was administered January 18–May 31, 2022. The study assessed current use (on one or more of the past 30 days) of e-cigarettes; frequency; and use by device type, flavors, and usual brand.
“This study shows that our nation’s youth continue to be enticed and hooked by an expanding variety of e-cigarette brands delivering flavored nicotine,” said Deirdre Lawrence Kittner, Ph.D., M.P.H., director of CDC’s Office on Smoking and Health. “Our work is far from over. It’s critical that we work together to prevent youth from starting to use any tobacco product – including e-cigarettes – and help all youth who do use them, to quit.”
Other Key Findings
“Adolescent e-cigarette use in the United States remains at concerning levels, and poses a serious public health risk to our nation’s youth,” said Brian King, Ph.D., M.P.H., director of the FDA’s Center for Tobacco Products. “Together with the CDC, protecting our nation’s youth from the dangers of tobacco products—including e-cigarettes—remains among the FDA’s highest priorities, and we are committed to combatting this issue with the breadth of our regulatory authorities.”
Due to changes in methodology, including differences in survey administration and data collection procedures in recent years due to the COVID-19 pandemic, the ability to compare estimates from 2022 with those from prior NYTS waves is limited; differences between estimates might be due to changes in methodology, actual behavior, or both.
Addressing Youth Tobacco Product Use
Youth use of tobacco products in any form, including e-cigarettes—is unsafe. Such products contain nicotine, which is highly addictive and can harm the developing adolescent brain. Using nicotine during adolescence might also increase risk for future addiction to other drugs.
Since 2014, e-cigarettes have been the most used tobacco product among U.S. youth. As the tobacco product landscape continues to change, the sustained implementation of comprehensive tobacco prevention and control strategies at the national, state, and local levels, coupled with FDA regulations, is critical to prevent and reduce youth access to and use of e-cigarettes.
For additional information, including quit resources, visit:
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
CDC works 24/7 protecting America’s health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.
To receive email updates about this page, enter your email address:
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.